Red-cell indices and iron status of the proband before (July 2002) and in the course of iron treatment
. | Normal values . | July 2002 . | February 2004 . |
|---|---|---|---|
| RBC count, × 1012/L | 4.5-4.7 | 4.98 | 5.46 |
| Hemoglobin, g/dL* | 11.0-15.0 | 7.5 | 8.8 |
| Hematocrit, %† | 35.0-42.0 | 26 | 28.7 |
| MCV, μm3 | 80.0-85.0 | 52.7 | 53 |
| MCH, pg | 25.0-28.0 | 15.10 | 16 |
| MCHC, g/dL | 30.0-36.0 | 28.7 | 31 |
| Reticulocytes, × 109/L (RBC count, %) | < 45 (< 1%) | 79 (1.6) | 49 (0.9) |
| Serum iron, μM/L | 11.0-24.0 | 28 | 29 |
| Transferrin, g/L | 2.2-4.0 | 1.64 | ND |
| TIBC, μM/L | 55-100 | 41 | 35 |
| Transferrin saturation, % | 16-35 | 68 | 84 |
| sTfR, mg/L | 0.83-1.76 | 8.29 | ND |
| Ferritinemia, μg/L | 14-130 | 18 | 56 |
| Erythrocyte ferritin, ag/cell | 4-18 | < 8 | ND |
. | Normal values . | July 2002 . | February 2004 . |
|---|---|---|---|
| RBC count, × 1012/L | 4.5-4.7 | 4.98 | 5.46 |
| Hemoglobin, g/dL* | 11.0-15.0 | 7.5 | 8.8 |
| Hematocrit, %† | 35.0-42.0 | 26 | 28.7 |
| MCV, μm3 | 80.0-85.0 | 52.7 | 53 |
| MCH, pg | 25.0-28.0 | 15.10 | 16 |
| MCHC, g/dL | 30.0-36.0 | 28.7 | 31 |
| Reticulocytes, × 109/L (RBC count, %) | < 45 (< 1%) | 79 (1.6) | 49 (0.9) |
| Serum iron, μM/L | 11.0-24.0 | 28 | 29 |
| Transferrin, g/L | 2.2-4.0 | 1.64 | ND |
| TIBC, μM/L | 55-100 | 41 | 35 |
| Transferrin saturation, % | 16-35 | 68 | 84 |
| sTfR, mg/L | 0.83-1.76 | 8.29 | ND |
| Ferritinemia, μg/L | 14-130 | 18 | 56 |
| Erythrocyte ferritin, ag/cell | 4-18 | < 8 | ND |